The Trump administration’s decision to impose sweeping export controls on Anthropic followed a frantic 24-hour effort by senior officials to convince the company to voluntarily pull a newly released ...

An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...

At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Photo: Christophe Gateau/dpa (Photo by Christophe Gateau/picture alliance via Getty Images) ...

Secure access service edge firm Versa Networks Inc. today introduced a zero-trust architecture for the Model Context Protocol that validates every action an artificial intelligence agent takes inside ...

Google just announced Gemini Omni, a new AI model that it claims can “create anything from any input,” at its annual I/O developer conference on Tuesday. The company said the model is starting off ...

Three years after the debut of ChatGPT, fooling A.I. systems into bad behavior is almost trivial. By Cade Metz and Tiffany Hsu Reporting from San Francisco When companies like Anthropic, Google and ...

With the June Twenty Twenty-Six compliance deadline approaching, RAS AP Consulting offers a turnkey assessment designed to close ACH fraud monitoring gaps across vendor master files, payment workflows ...

A recent security incident involving Anthropic has highlighted just how fragile the safeguards around advanced AI systems can be. A Wired report suggests that a small group of users, operating through ...

The maker of ChatGPT is taking a more open approach to cybersecurity than its chief rival, Anthropic. By Cade Metz Reporting from San Francisco The artificial intelligence company Anthropic said this ...

AACR was full of biotechs showcasing their preclinical Ras candidates, including Clasp Therapeutics, Verastem Oncology and BlossomHill Therapeutics. (Darren Incorvaia) After dropping headline-grabbing ...

OpenAI Group PBC today announced the launch of GPT-5.4-Cyber, a fine-tuned variant of its GPT-5.4 model designed for defensive cybersecurity work and also announced a significant expansion of its ...